15.46

15.37% 2.06

Sellas Life Sciences Group Inc (SLS)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt SLS? Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$13.40

Offen:

$13.69

24-Stunden-Volumen:

15.15M

Relative Volume:

1.68

Marktkapitalisierung:

$3.12B

Einnahmen:

Nettoeinkommen (Verlust:

$-29.46M

KGV:

-67.72

EPS:

-0.2283

Netto-Cashflow:

$-28.17M

1W Leistung:

+20.97%

1M Leistung:

+19.84%

6M Leistung:

+272.53%

1J Leistung:

+778.41%

1-Tages-Spanne:

$13.26

$15.67

1-Wochen-Bereich:

$12.39

$15.67

52-Wochen-Spanne:

$1.39

$15.88

Sellas Life Sciences Group Inc Stock (SLS) Company Profile

Firmenname

Sellas Life Sciences Group Inc

Sektor

Healthcare (1080)

Branche

Biotechnology (604)

Telefon

(646) 200-5278

Adresse

7 TIMES SQUARE, NEW YORK, NY

Mitarbeiter

Twitter

Nächster Verdiensttermin

2026-08-11

Neueste SEC-Einreichungen

SLS's Discussions on Twitter

Compare SLS vs VRTX, REGN, ARGX, MRNA, RVMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
SLS Sellas Life Sciences Group Inc	15.46	2.71B	0	-29.46M	-28.17M	-0.2283
VRTX Vertex Pharmaceuticals Inc	548.05	136.93B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	834.04	85.11B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,039.78	64.95B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	145.13	53.23B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	209.46	45.38B	742.00K	-1.37B	-1.07B	-7.0731

Sellas Life Sciences Group Inc Stock (SLS) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2021-07-21	Eingeleitet	Cantor Fitzgerald	Overweight
2018-11-01	Eingeleitet	Oppenheimer	Outperform
2018-04-02	Eingeleitet	H.C. Wainwright	Buy
2018-03-19	Hochstufung	Maxim Group	Hold → Buy

Sellas Life Sciences Group Inc Aktie (SLS) Neueste Nachrichten

Aug 22, 2026

Are SELLAS Life Sciences (SLS) Loss Trends Masking a Shifting Cancer Vaccine Investment Narrative? - simplywall.st

Aug 22, 2026

Aug 21, 2026

Sellas Life Sciences Rides a Sector Wave as Its Own Leukemia Trial Hits the Home Stretch - Ad-hoc-news.de

Aug 21, 2026

SLS Stock Extends Rally Overnight: CEO Says ‘Bullish’ Leukemia Data Could Drive NCCN Recognition For GPS - Stocktwits

Aug 21, 2026

SLS Stock Clocks Three Straight Weeks Of Gains On Cancer Vaccine Spillover, REGAL Trial Data Anticipation - Yahoo Finance

Aug 21, 2026

SELLAS Shares Climb 15% as Market Values Company $2.98 Billion Over Cash Pre-AML Update - TechStock²

Aug 21, 2026

Sebring Design Build Featured in Newsweek on Why Affluent Williamson County Homeowners Are Remodeling Instead of Moving - Yahoo Finance

Aug 21, 2026

Why SELLAS Life Sciences Group (SLS) Stock Is Up Today - Quiver Quantitative

Aug 21, 2026

SLS, IBRX Eye Green Month As Biotech ETF Gains Steam: Analyst Sees ‘Continued Opportunities’ In Immuno-Oncology - Stocktwits

Aug 21, 2026

Can STERIS Stock Deliver as Its $600 Million Chemistry Bet Scales? - Yahoo Finance

Aug 21, 2026

OSR Health: Preparing Our Appeal, Advancing Our Catalysts, Continuing Our Mission - Yahoo Finance

Aug 21, 2026

Citadel Sold More Than $4 Billion of Situational Awareness Bets - Yahoo Finance

Aug 21, 2026

Is the Options Market Predicting a Spike in Latham Group Stock? - Yahoo Finance

Aug 21, 2026

IQVIA Holdings Stock Outlook: Is Wall Street Bullish or Bearish? - Yahoo Finance

Aug 21, 2026

Goldman Says Slowing Inflation Is Best Path to Lower US Yields - Yahoo Finance

Aug 21, 2026

Is SELLAS (SLS) Turning Sector Hype Into a Durable Cancer Vaccine Story Despite Ongoing Losses? - Yahoo Finance

Aug 21, 2026

SELLAS Life Sciences Soars 7.9x in Three Years, But Valuation Screens as Stretched - finance.biggo.com

Aug 21, 2026

SELLAS Life Sciences Group (SLS) Shares Just Moved, So What Is Drawing Attention? - Yahoo Finance

Aug 21, 2026

SELLAS Life Sciences Group (SLS) Stock Looks Stretched Despite Key AML Trial Progress - Yahoo Finance

Aug 21, 2026

Aug 20, 2026

SLS Stock Pops Big After Hours On Imminent Leukemia Trial Data Readout Optimism - Stocktwits

Aug 20, 2026

SLS Stock Edges Higher As Wall Street, Retail Expect Another MRNA Moment - Stocktwits

Aug 20, 2026

SLS Stock Tests $5 Again: Retail Targets ‘No’ Vote On 20M Share Dilution Push Before AML Trial Results - Stocktwits

Aug 20, 2026

SLS Stock Slides Premarket: Traders Brace For Key Arbitration Ruling In GPS China Payment Dispute - Stocktwits

Aug 20, 2026

Maxim Group Maintains Sellas Life Sciences(SLS.US) With Buy Rating, Maintains Target Price $30 - Moomoo

Aug 20, 2026

SLS Stock Kicks Off Week In Green: CEO Flags Role In EU Biotech Policy Talks That Could Impact Drug Approvals - Stocktwits

Aug 20, 2026

SLS Short Interest Hits All-Time High: Sellas Bulls Smell A Short Squeeze As Executive Contract Changes Fuel Buyout Chatter - Stocktwits

Aug 20, 2026

Sellas Life Sciences Draws Significant Retail Buzz As Traders Eye REGAL Phase 3 Catalyst – SLS Stock Soars 15% - Stocktwits

Aug 20, 2026

SLS Stock Rises Overnight: Retail Traders Call New AML Survival Data 'Huge' Ahead Of CEO’s Fox Appearance - Stocktwits

Aug 20, 2026

SLS Stock Rises Overnight: Traders Rally Behind Jim Cramer's 'Two Thumbs Up' Call Ahead Of Key AML Readout - Stocktwits

Aug 20, 2026

SLS Stock Surges Toward Fifth Weekly Rise: CEO Touts GPS As Lifeline For Elderly Patients As Cancer Summit Looms - Stocktwits

Aug 20, 2026

SLS Stock Jumps Premarket: CEO Says GPS AML Data Has ‘Very Good Chance’ To Beat Earlier Survival Outcomes - Stocktwits

Aug 20, 2026

SLS Stock Hits Over 4-Year High: CEO Eyes FDA Talks, ‘Whole Gamut’ Of Cancer Uses For GPS - Stocktwits

Aug 20, 2026

SLS Stock Sparks Retail Buzz Ahead of AACR Presentation On Experimental Cancer Therapy - Stocktwits

Aug 20, 2026

Why Did SLS, BB, OUST Stocks Surge To 52-Week Highs Today? - Stocktwits

Aug 20, 2026

Aug 19, 2026